Antiparkinson Agents
This graph shows the total number of publications written about "Antiparkinson Agents" by people in the URMC Research Network by year, and whether "Antiparkinson Agents" was a major or minor topic of these publication.
Below are the most recent publications written about "Antiparkinson Agents" by people in Profiles.
-
LeWitt P, Schultz L, Auinger P, Lu M. CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease. Brain Res. 2011 Aug 23; 1408:88-97.
-
Hauser RA, Auinger P. Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord. 2011 Apr; 26(5):813-8.
-
Kieburtz K. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial. Mov Disord. 2011 Jan; 26(1):37-44.
-
Schapira AH, Albrecht S, Barone P, Comella CL, McDermott MP, Mizuno Y, Poewe W, Rascol O, Marek K. Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study. Mov Disord. 2010 Aug 15; 25(11):1627-32.
-
Stocchi F, Rascol O, Kieburtz K, Poewe W, Jankovic J, Tolosa E, Barone P, Lang AE, Olanow CW. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27.
-
Hauser RA, Auinger P, Oakes D. Levodopa response in early Parkinson's disease. Mov Disord. 2009 Dec 15; 24(16):2328-36.
-
Kieburtz K. ADAGIO misses a beat? Lancet Neurol. 2009 Dec; 8(12):1081-2.
-
Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology. 2009 Nov 3; 73(18):1469-77.
-
Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG. Selegiline shortage: Causes and costs of a generic drug shortage. Neurology. 2009 Jul 21; 73(3):213-7.
-
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
